AZD1480 50mg 50mg | Purity Not Available
Adooq Bioscience
AZD1480 is a novel potent small JAK2 inhibitor with an IC50 of 0.26 nM.
More Information Supplier PageAZD1480 is a novel potent small JAK2 inhibitor with an IC50 of 0.26 nM.
More Information Supplier PageAZD1480 is a novel potent small JAK2 inhibitor with an IC50 of 0.26 nM.
More Information Supplier PageAZD1480 is a novel potent small JAK2 inhibitor with an IC50 of 0.26 nM.
More Information Supplier PageAZD1480 is a novel potent small JAK2 inhibitor with an IC50 of 0.26 nM.
More Information Supplier PageAzacitidine is a chemical analogue of the cytosine nucleoside used in DNA and RNA that is mainly used in the treatment of myelodysplastic syndrome (MDS).
More Information Supplier PageAzacitidine is a chemical analogue of the cytosine nucleoside used in DNA and RNA that is mainly used in the treatment of myelodysplastic syndrome (MDS).
More Information Supplier PageAzacitidine is a chemical analogue of the cytosine nucleoside used in DNA and RNA that is mainly used in the treatment of myelodysplastic syndrome (MDS).
More Information Supplier PageAzacitidine is a chemical analogue of the cytosine nucleoside used in DNA and RNA that is mainly used in the treatment of myelodysplastic syndrome (MDS).
More Information Supplier PageAZ-960 is a potent, selective and ATP competitive JAK2 inhibitor that inhibits JAK2 kinase with a Ki of 0.45 nM in vitro and induces growth arrest and apoptosis in adult T-cell leukemia (ATL) cell.
More Information Supplier PageAZ-960 is a potent, selective and ATP competitive JAK2 inhibitor that inhibits JAK2 kinase with a Ki of 0.45 nM in vitro and induces growth arrest and apoptosis in adult T-cell leukemia (ATL) cell.
More Information Supplier Page